{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-361760","form_type":"8-K","ticker":"CRSP","cik":"0001674416","company_name":"CRISPR Therapeutics AG","filed_at":"2021-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.597832+00:00","generated_at":"2026-06-27T23:44:07.547747+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CRISPR Therapeutics terminates EVP R&D Tony W. Ho without cause","bullets":["Tony W. Ho terminated as Executive Vice President, Research and Development on December 14, 2021.","Termination is without cause and not the result of any disagreement with the Company.","No replacement has been announced; Samarth Kulkarni remains CEO."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-361760","json":"https://secwatch.observer/filing/0001193125-21-361760.json","markdown":"https://secwatch.observer/filing/0001193125-21-361760.md","text":"https://secwatch.observer/filing/0001193125-21-361760.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1674416/000119312521361760/0001193125-21-361760-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1674416/000119312521361760/d274235d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T23:44:07.547747+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e2118d14d4","claim":"Tony W. Ho was terminated as Executive Vice President, Research and Development at CRISPR Therapeutics AG.","evidence_excerpt":"On December 14, 2021, Tony W. Ho was terminated from his position as Executive Vice President, Research and Development of CRISPR Therapeutics AG (the “Company”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1674416/000119312521361760/0001193125-21-361760-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Executive Vice President, Research and Development"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}